Biotech Values

[oc631]

I've never thought much about BCRX. How many clinical trials has peramivir already failed? I remember the one from several years ago where they claimed the needles weren't long enough or something. Seemed like a joke to me. Also, gout is becoming an increasingly crowded field and they are behind a lot of people. Not sure of anything that differentiates their gout drug from the competition.

They are also developing a HCV nucleoside analog sans the prodrug strategy which I doubt should be taken seriously.